Compounds and methods for treating bacterial infections

US9540394B2 · kind B2 · utility

Assignee

• Entasis Therapeutics, Inc. · US

Inventors

• Gregory Steven Basarab · Hockessin, US
• Madhusudhan Reddy Gowravaram · Waltham, US
• Sheila Hauck · Waltham, US
• Fei Zhou · Shanghai, CN

Key dates

• Filing date: Oct 13, 2015
• Grant date: Jan 10, 2017
• Expiry date: Oct 13, 2035

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds of formula (I), pharmaceutically acceptable salts thereof, and uses of the compounds of formula (I) for treating bacterial infections are disclosed.